Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Cel-Sci completes private placement

February 24, 2017 2:18 AM UTC

On Feb. 17, cancer and infectious disease company Cel-Sci Corp. (NYSE-M:CVM) raised $1 million through the sale of 10 million shares at $0.10 in a registered direct offering to institutional investors...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Cel-sci Corp.